Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
In this research study the investigators are looking for the highest dose of a stereotactic
radiation boost that can be given safely. Because stereotactic radiation is so precise, the
investigators are testing whether it can be used to increase the dose to the primary tumor
without significantly increasing the side effects the participant experiences; the goal is to
improve the likelihood of killing the tumor.